Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 121 recruiting studies, sorted by proximity — each links to its official registry page
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Community Memorial Health System — Ventura, California (8.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Thousand Oaks, California (19.7 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Incyte Corporation
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
The Cohen Medical Centers — Thousand Oaks, California (19.7 mi)
· Sponsor: Takeda
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Penumbra Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Cohen Medical Centers — Thousand Oaks, California (19.7 mi)
· Sponsor: Crystalys Therapeutics
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Medtronic Cardiovascular
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Care Access Research — Thousand Oaks, California (19.7 mi)
· Sponsor: Boehringer Ingelheim
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
Motiva Implants® Post-Approval Study
Breast Implant
N/A
Interventional 2,400 participants sought
Schwartz Aesthetic Institute — Westlake Village, California (21.8 mi)
· Sponsor: Motiva USA LLC
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Clinical Trials Management Services — Thousand Oaks, California (19.7 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Camarillo, California (8.3 mi)
· Sponsor: 89bio, Inc.
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Ventura County Hematology Oncology Specialists — Oxnard, California (0.3 mi)
· Sponsor: Paradigm Health
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2, Phase 3
Interventional 274 participants sought
California Retina Consultants — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Oxnard-70187 — Oxnard, California (0.3 mi)
· Sponsor: Boehringer Ingelheim
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Phase 3
Interventional 1,000 participants sought
Accellacare - Moorpark — Moorpark, California (18.2 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Clinica mi Salud by Focil Med — Oxnard, California (0.3 mi)
· Sponsor: Pfizer
Abbott Cephea Mitral Valve Disease Registry
Mitral Regurgitation, Mitral Stenosis
N/A
Observational 1,000 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Abbott Medical Devices
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Millennium Clinical Trials — Westlake Village, California (21.8 mi)
· Sponsor: Novartis Pharmaceuticals
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7107 — Thousand Oaks, California (19.7 mi)
· Sponsor: Galderma R&D
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Colitis, Ulcerative, Crohn Disease
Phase 2
Interventional 60 participants sought
Om Research LLC — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
California Retina Consultants — Oxnard, California (0.3 mi)
· Sponsor: Regeneron Pharmaceuticals